Physician profile
Mario Binder
NPI 1265457022
$1,923.73
in general payments reported to CMS, 2019-2025
16 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $368 · 2021: $263 · 2022: $201 · 2023: $179 · 2024: $136 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $527.78 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $358.70 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $329.10 | 2019-2024 | |
| Pfizer INC. | $297.79 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $97.89 | 2019-2020 | |
| Genentech USA, INC. | $86.69 | 2025 | Xolair |
| Atricure, INC. | $41.71 | 2024 | |
| Janssen Pharmaceuticals, INC | $39.36 | 2019 | |
| Merck Sharp & Dohme LLC | $30.00 | 2022 | |
| Alnylam Pharmaceuticals INC. | $20.93 | 2022 | |
| Boston Scientific Corporation | $20.00 | 2020 | |
| Medtronic, INC. | $15.91 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $15.50 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.00 | 2019 | |
| Cleerly, INC. | $13.84 | 2025 | Cleerly Labs, Cleerly Ischemia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $13.53 | 2023 | Sapien 3 Ultra Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Binder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.